Red Cat Holdings, Inc. ( RCAT ) for Q3 '25 reported an EPS loss of about –$0.16, missing expectations by$0.07. Elsewhere, revenue came in at $9.65 million, well below the$14.12 million consensus. The market reaction obviously wasn't good, and shares areI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific ...